Pharma and Wearables Report 2016 - What are Wearables and How are They Impacting Pharma? - Research and Markets

DUBLIN, July 20, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Wearables are Transforming R&D and Care Delivery" report to their offering.

Wearables encompass the growing range of gadgets that can be attached to the body to measure certain physiological parameters. They are rapidly being adopted in healthcare, as part of a broader health IT revolution, with significant consequences for pharma in both the economics and execution of R&D. There are already an estimated 300 trials underway involving wearables, according to National Institutes of Health data reported in late 2015. Wearables' most immediate potential is in chronic diseases.

This report addresses the following questions:

- What are wearables and how are they impacting pharma?
- Who is developing wearables and what partnerships have pharma companies forged as they venture into this new domain?
- What are the key drivers and resistors to wearables' use in healthcare?
- How has pharma experimented with wearables so far and what are the key takeaways for drug developers?
- What impact have wearables had on pharma R&D so far?
- How will wearables fit within the pharma business model and where is there most potential to generate return on investment from wearables?

Key Topics Covered:

1. What are wearables, and why should pharma care?

2. Wearables makers: pharma partners or competitors?

3. Wearables' early impact in R&D and beyond

4. Drivers and resistors of wearables in healthcare

5. Case studies involve a range of players, devices, and therapy areas

6. Wearables are part of digital health investments

What are Wearables, and Why Should Pharma Care?

7. Wellness and medicine: blurring boundaries

8. Enabling patient centricity; lowering costs

9. Bibliography

Wearables Makers: Pharma Partners or Competitors?

10. Who is making wearables?

11. Fostering and funding digital health innovation

12. Bibliography

Wearables' Early Impact in R&D and Beyond

13. Most wearables trials to date have been feasibility studies

14. Bibliography

Drivers and Resistors of Wearables in Healthcare

15. Drivers

16. Resistors

17. Bibliography

Wearables Case Studies

18. Wearables are used along the value chain and across stakeholders

19. Biogen-Google: uncovering the course of multiple sclerosis

20. Novartis-Qualcomm: building the foundations for mobile trials

21. Novartis-Microsoft: measuring multiple sclerosis

22. UCB-MC10: improving diagnosis and treatment of Parkinson's disease

23. Johns Hopkins-Apple: using Apple Watch to predict seizures

24. UnitedHealthcare-Qualcomm: paying for steps

25. Medibio-Medtronic: diagnosing depression

26. Google (Verily)-Dexcom: stick-on glucose monitors for diabetes

27. Otsuka-Proteus Digital Health: digital medicines may improve outcomes but first must pass regulatory muster

28. Bibliography

Wearables are Part of Digital Health Investments

29. Unquantified investments

30. Efficacy gains expected

31. Who will pay for wearables in healthcare?

32. The technological future, 33. Bibliography

For more information visit http://www.researchandmarkets.com/research/66rbwv/wearables_are

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets